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Fig 2. Haematoxylin and eosin staining of a chondrosarcoma. 
(From Thompson KG, Dittmer KE. 2017. Tumors of bone. In: 
Meuten DJ, editor. Tumors in domestic animals) 1.
Fig 1. Haematoxylin and eosin staining of a vertebral osteoblastic 
osteosarcoma. (Courtesy of the Mouse and Comparative Pathology 
Unit, UAB).
Fig 3. Haematoxylin and eosin staining of a bone fibrosarcoma. (Courtesy of 
the Mouse and Comparative Pathology Unit, UAB).
Fig 5. Vimentin immunohistochemistry labelling. (Courtesy of the Mouse and 
Comparative Pathology Unit, UAB).
Canine Extradural Spinal Neoplasms: 
Histologic Biomarkers as a Diagnostic Approach
Fig 4. Haematoxylin and eosin staining of an osteoblastic
osteosarcoma. Note the striped artefacts caused by decalcification
and sample processing (*). (Courtesy of the Mouse and
Comparative Pathology Unit, UAB).
Fig 6. Algorithm to canine spinal bone neoplasia using immunohistochemical biomarkers. VIM Vimentin, ALP
Alkaline phosphatase, OC Osteocalcin, GAL1 Galectin-1.
 Extradural spinal tumours are the most
frequent type of spinal tumours in dogs, and
bone neoplasms are highly overrepresented.
 Clinical signs are caused by focal
compression or invasion of the spinal cord,
mostly showing pain and neurological
deficits, and most of the times they carry a
very poor prognosis.
 Diagnosis of such tumours relies basically on
histopathological studies, although their
microscopic appearance is very similar and
useful diagnostic biomarkers are lacking.
 This review intended to shine some light into
canine extradural bone tumours and analyse




































Introduction and objectives Main extradural spinal tumours
Diagnostic and prognostic biomarkers
 Vimentin indicates mesenchymal origin. Low immunoreactivity
correlates with better prognosis.
 Alkaline phosphatase is present in all osteoblasts. Elevated serum
levels indicate poor prognosis.
 Osteocalcin is a late osteoblastic differentiation marker. Loss of
expression indicates poor prognosis.
 Diagnosis of extradural spinal bone tumours is currently a very difficult task that relies mainly in immunohistochemistry and diagnostic biomarkers.
 Decalcification procedures are compulsory for this type of studies and may alter the obtained results.
 Further investigation is needed in search for more reliable biomarkers, especially those able to distinguish among osteosarcoma and
chondrosarcoma, since they are the two most common bone tumours in dogs.
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Table 1. The three most common bone tumours, their incidence 
















Central, periosteal and 
mandibular or maxillary bone 
fibrosarcoma of the dog
 Ezrin and Galectin1 may distinguish
osteosarcomas from chondrosarcomas.
 Snail2 is a promoter of osteoblastic
differentiation. Prognostic implications in
appendicular osteosarcomas.
 STAT3, TP53 and c-MET indicate malignancy.
